Drug intelligence / Profile preview

ammonia + povidone-iodine + triamcinolone acetonide + lidocaine

Development stage: Unknown
Lead developer: Asclemed USA
Modality: Small Molecules
Administration: Intramuscular, Intraarticular, Topical, Inhalation

Overview

A multi-component combination kit marketed as **Physician EZ Use Joint Tunnel and Trigger Kit** and associated with **Asclemed USA**. The product contains triamcinolone acetonide, lidocaine, povidone-iodine, and ammonia for procedure-based musculoskeletal use, including intra-articular and intramuscular administration contexts. The principal therapeutic component is **triamcinolone acetonide**, a synthetic glucocorticoid corticosteroid that exerts anti-inflammatory and immunosuppressive effects via the glucocorticoid receptor; **lidocaine** provides local anesthetic activity by blocking voltage-gated sodium channels; **povidone-iodine** serves as a topical antiseptic; and **ammonia** is included as an inhalant component. The combination is best understood as an unapproved small-molecule drug kit assembled for joint, tunnel, and trigger-point style injection procedures rather than as a novel molecular entity.

Brand names: Physician EZ Use Joint Tunnel and Trigger Kit
Other names: ammonia + povidone-iodine + triamcinolone acetonide + lidocaine

Targets

GR (Glucocorticoid receptor)NaV (Voltage-gated sodium channels)

Beyond the preview

Go deeper on ammonia + povidone-iodine + triamcinolone acetonide + lidocaine.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on ammonia + povidone-iodine + triamcinolone acetonide + lidocaine.

Explore the full profile